Erythema
1
Pipeline Programs
2
Companies
4
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
BayerLEVERKUSEN, Germany
2 programs1
Dexpanthenol foam spray, new formulationPhase 22 trials
BAY207543N/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
BayerDexpanthenol foam spray, new formulation
BayerDexpanthenol foam spray, new formulation
BayerBAY207543
CAGE BioCB-0002B
Clinical Trials (4)
Total enrollment: 107 patients across 4 trials
Efficacy of Dexpanthenol in Thermic Erythema
Start: Sep 2007Est. completion: Sep 200755 patients
Phase 2Completed
Moisturizing Effect of Two Dexpanthenol Formulations
Start: Aug 2007Est. completion: Sep 200719 patients
Phase 2Completed
A Study to Gain Information How Well Dexpanthenol Derma Cream Helps the Face Skin to Recover After Cosmetic Lasering
Start: Mar 2019Est. completion: Apr 201933 patients
N/ACompleted
50 Human Subject Repeat Insult Patch Test
Start: Jan 2017Est. completion: Mar 2017
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space